Robert Aslanian

2.0k total citations
83 papers, 1.4k citations indexed

About

Robert Aslanian is a scholar working on Molecular Biology, Organic Chemistry and Immunology. According to data from OpenAlex, Robert Aslanian has authored 83 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 27 papers in Organic Chemistry and 23 papers in Immunology. Recurrent topics in Robert Aslanian's work include Mast cells and histamine (23 papers), Receptor Mechanisms and Signaling (19 papers) and Chemical Synthesis and Analysis (9 papers). Robert Aslanian is often cited by papers focused on Mast cells and histamine (23 papers), Receptor Mechanisms and Signaling (19 papers) and Chemical Synthesis and Analysis (9 papers). Robert Aslanian collaborates with scholars based in United States, United Kingdom and Sweden. Robert Aslanian's co-authors include Anandan Palani, Xianhai Huang, Pauline C. Ting, John A. Hey, John J. Piwinski, Ning Shao, Neng‐Yang Shih, Jan‐E. Bäckvall, Alexei V. Buevich and Dong Xiao and has published in prestigious journals such as Journal of the American Chemical Society, The FASEB Journal and Journal of Medicinal Chemistry.

In The Last Decade

Robert Aslanian

83 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Aslanian United States 23 756 623 243 109 104 83 1.4k
Neng‐Yang Shih United States 20 583 0.8× 564 0.9× 303 1.2× 90 0.8× 91 0.9× 57 1.3k
Shin‐ichi Tsukamoto Japan 22 652 0.9× 765 1.2× 117 0.5× 123 1.1× 88 0.8× 71 1.6k
John J. Piwinski United States 21 565 0.7× 538 0.9× 103 0.4× 122 1.1× 54 0.5× 49 1.1k
Roland Feifel Switzerland 21 338 0.4× 769 1.2× 155 0.6× 85 0.8× 75 0.7× 36 1.3k
Simon E. Ward United Kingdom 22 421 0.6× 933 1.5× 86 0.4× 142 1.3× 41 0.4× 67 1.6k
Yuko Otani Japan 23 800 1.1× 806 1.3× 125 0.5× 48 0.4× 110 1.1× 81 1.6k
Carina Shayo Argentina 22 535 0.7× 750 1.2× 350 1.4× 232 2.1× 118 1.1× 56 1.7k
Nigel J. Liverton United States 24 711 0.9× 726 1.2× 121 0.5× 103 0.9× 102 1.0× 61 1.8k
Obbe P. Zuiderveld Netherlands 19 450 0.6× 600 1.0× 426 1.8× 39 0.4× 95 0.9× 33 1.1k
Michael A. Stashko United States 23 340 0.4× 708 1.1× 491 2.0× 152 1.4× 99 1.0× 51 1.5k

Countries citing papers authored by Robert Aslanian

Since Specialization
Citations

This map shows the geographic impact of Robert Aslanian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Aslanian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Aslanian more than expected).

Fields of papers citing papers by Robert Aslanian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Aslanian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Aslanian. The network helps show where Robert Aslanian may publish in the future.

Co-authorship network of co-authors of Robert Aslanian

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Aslanian. A scholar is included among the top collaborators of Robert Aslanian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Aslanian. Robert Aslanian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Xianhai, Wei Zhou, Robert Aslanian, et al.. (2017). The synthesis of 2,3,6-trisubstituted 1-oxo-1,2-dihydroisoquinolines as potent CRTh2 antagonists. Bioorganic & Medicinal Chemistry Letters. 27(23). 5344–5348. 7 indexed citations
2.
Aslanian, Robert, Tanweer A. Khan, Rongze Kuang, et al.. (2015). Discovery of aminoquinazoline derivatives as human A2A adenosine receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 26(4). 1348–1354. 7 indexed citations
3.
Zeng, Qingbei, Stuart B. Rosenblum, Zhaoxia Yang, et al.. (2013). Synthesis and SAR studies of benzimidazolone derivatives as histamine H3-receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 23(21). 6001–6003. 5 indexed citations
4.
Huang, Xianhai & Robert Aslanian. (2012). Case studies in modern drug discovery and development. John Wiley & Sons eBooks. 12 indexed citations
5.
Shao, Ning, Robert Aslanian, Robert E. West, et al.. (2012). Synthesis and structure–activity relationship (SAR) study of 4-azabenzoxazole analogues as H3 antagonists. Bioorganic & Medicinal Chemistry Letters. 22(5). 2075–2078. 4 indexed citations
6.
Xiao, Dong, Anandan Palani, Robert Aslanian, et al.. (2012). Fused bicycles as arylketone bioisosteres leading to potent, orally active thiadiazole H3 antagonists. Bioorganic & Medicinal Chemistry Letters. 22(9). 3354–3357. 3 indexed citations
7.
Ting, Pauline C., Nicolas F. Zorn, Hyunjin M. Kim, et al.. (2012). Lead optimization of a pyridine-carboxamide series as DGAT-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(4). 985–988. 8 indexed citations
8.
Huang, Xianhai, Jing Su, Wei Zhou, et al.. (2011). SAR studies of C2 ethers of 2H-pyrano[2,3-d]pyrimidine-2,4,7(1H,3H)-triones as nicotinic acid receptor (NAR) agonist. Bioorganic & Medicinal Chemistry Letters. 22(2). 854–858. 12 indexed citations
9.
McCormick, Kevin D., Robert Aslanian, Michael Berlin, et al.. (2011). Steroidal C-21 heteroaryl thioethers (Part 2): Discovery of orally bioavailable selective glucocorticoid receptor modulators (dissociated steroids). Bioorganic & Medicinal Chemistry Letters. 22(2). 1086–1090. 4 indexed citations
10.
Huang, Xianhai, Xiaohong Zhu, Xiaohong Chen, et al.. (2011). A three-step protocol for lead optimization: Quick identification of key conformational features and functional groups in the SAR studies of non-ATP competitive MK2 (MAPKAPK2) inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(1). 65–70. 18 indexed citations
11.
Berlin, Michael, Christopher W. Boyce, Yi Wang, et al.. (2010). Reduction of hERG inhibitory activity in the 4-piperidinyl urea series of H3 antagonists. Bioorganic & Medicinal Chemistry Letters. 20(7). 2359–2364. 10 indexed citations
12.
Xiao, Dong, Cheng Wang, Anandan Palani, et al.. (2010). Discovery of a series of potent, orally active α,α-disubstituted piperidine NK1 antagonists. Bioorganic & Medicinal Chemistry Letters. 20(21). 6313–6315. 10 indexed citations
13.
Palani, Anandan, Xiao Cheng, Ying Huang, et al.. (2009). Synthesis and structure–activity relationships of 2-(1,4′-bipiperidin-1′-yl)thiazolopyridine as H3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 19(21). 6176–6180. 32 indexed citations
14.
Pramanik, Birendra N., Robert Aslanian, Vincent P. Gullo, et al.. (2008). Isolation, structural determination, synthesis and quantitative determination of impurities in Intron-A, leached from a silicone tubing. Journal of Pharmaceutical and Biomedical Analysis. 49(2). 327–332. 5 indexed citations
15.
Vaccaro, Wayne, Rosy Sher, Michael Berlin, et al.. (2005). Novel histamine H3 receptor antagonists based on the 4-[(1H-imidazol-4-yl)methyl]piperidine scaffold. Bioorganic & Medicinal Chemistry Letters. 16(2). 395–399. 4 indexed citations
16.
Ting, Pauline C., Shelby P. Umland, Robert Aslanian, et al.. (2005). The synthesis of substituted bipiperidine amide compounds as CCR3 ligands: Antagonists versus agonists. Bioorganic & Medicinal Chemistry Letters. 15(12). 3020–3023. 15 indexed citations
17.
Yang, Richard, John A. Hey, Robert Aslanian, & Charles A. Rizzo. (2002). Coordination of Histamine H<sub>3</sub> Receptor Antagonists with Human Adrenal Cytochrome P450 Enzymes. Pharmacology. 66(3). 128–135. 66 indexed citations
18.
Reichard, Gregory A., Robert Aslanian, Ling Lin, et al.. (2002). Structure–Activity relationships of oxime neurokinin antagonists: oxime modifications. Bioorganic & Medicinal Chemistry Letters. 12(5). 833–836. 2 indexed citations
19.
Reichard, Gregory A., Zachary T. Ball, Robert Aslanian, et al.. (2000). The design and synthesis of novel NK1/NK2 dual antagonists. Bioorganic & Medicinal Chemistry Letters. 10(20). 2329–2332. 19 indexed citations
20.
Aslanian, Robert, N.‐Y. SHIH, Michael J. Green, et al.. (1998). 4- [(1H - imidazol - 4 - YL) methyl] benzamidines and benzylamidines: novel antagonists of the histamine H3 receptor. Bioorganic & Medicinal Chemistry Letters. 8(16). 2263–2268. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Neng‐Yang Shih Breakdown of academic impact, for papers by Shin‐ichi Tsukamoto Breakdown of academic impact, for papers by John J. Piwinski Breakdown of academic impact, for papers by Roland Feifel Breakdown of academic impact, for papers by Simon E. Ward Breakdown of academic impact, for papers by Yuko Otani Breakdown of academic impact, for papers by Carina Shayo Breakdown of academic impact, for papers by Nigel J. Liverton Breakdown of academic impact, for papers by Obbe P. Zuiderveld Breakdown of academic impact, for papers by Michael A. Stashko
Rankless by CCL
2026